This report contains market size and forecasts of Peptic Ulcer Drugs in Global, including the following market information:
Global Peptic Ulcer Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Peptic Ulcer Drugs market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Proton Pump Inhibitors Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Peptic Ulcer Drugs include AstraZeneca, Livzon Pharmaceutical, Jiangsu Aosaikang Pharmaceutical, CTTQ, Luoxin Pharmaceuticals, Takeda, Eisai, Jumpcan Pharmaceutical and Zhejiang Conba Pharmaceutical, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peptic Ulcer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptic Ulcer Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Peptic Ulcer Drugs Market Segment Percentages, by Type, 2022 (%)
Proton Pump Inhibitors
Antacids
H2-Receptor Antagonists
Others
Global Peptic Ulcer Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Peptic Ulcer Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital and Clinic
Pharmacy
Global Peptic Ulcer Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Peptic Ulcer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptic Ulcer Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Peptic Ulcer Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Livzon Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
CTTQ
Luoxin Pharmaceuticals
Takeda
Eisai
Jumpcan Pharmaceutical
Zhejiang Conba Pharmaceutical
Youcare Pharmaceutical
Chongqing Lummy Pharmaceutical
Huadong Medicine
Hansoh Pharmaceutical
CR Double-Crane
Hunan Warrant Pharmaceutical
Changzhou Siyao Pharmaceuticals
Chongqing Pharscin Pharmaceutical
Lionco Pharmaceutical
Jiangsu Wuzhong Pharmaceutical
Cisen Pharmaceutical
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Peptic Ulcer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peptic Ulcer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peptic Ulcer Drugs Overall Market Size
2.1 Global Peptic Ulcer Drugs Market Size: 2022 VS 2030
2.2 Global Peptic Ulcer Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peptic Ulcer Drugs Players in Global Market
3.2 Top Global Peptic Ulcer Drugs Companies Ranked by Revenue
3.3 Global Peptic Ulcer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Peptic Ulcer Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Peptic Ulcer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptic Ulcer Drugs Players in Global Market
3.6.1 List of Global Tier 1 Peptic Ulcer Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Peptic Ulcer Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Peptic Ulcer Drugs Market Size Markets, 2022 & 2030
4.1.2 Proton Pump Inhibitors
4.1.3 Antacids
4.1.4 H2-Receptor Antagonists
4.1.5 Others
4.2 By Type - Global Peptic Ulcer Drugs Revenue & Forecasts
4.2.1 By Type - Global Peptic Ulcer Drugs Revenue, 2018-2023
4.2.2 By Type - Global Peptic Ulcer Drugs Revenue, 2023-2030
4.2.3 By Type - Global Peptic Ulcer Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peptic Ulcer Drugs Market Size, 2022 & 2030
5.1.2 Hospital and Clinic
5.1.3 Pharmacy
5.2 By Application - Global Peptic Ulcer Drugs Revenue & Forecasts
5.2.1 By Application - Global Peptic Ulcer Drugs Revenue, 2018-2023
5.2.2 By Application - Global Peptic Ulcer Drugs Revenue, 2023-2030
5.2.3 By Application - Global Peptic Ulcer Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Peptic Ulcer Drugs Market Size, 2022 & 2030
6.2 By Region - Global Peptic Ulcer Drugs Revenue & Forecasts
6.2.1 By Region - Global Peptic Ulcer Drugs Revenue, 2018-2023
6.2.2 By Region - Global Peptic Ulcer Drugs Revenue, 2023-2030
6.2.3 By Region - Global Peptic Ulcer Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Peptic Ulcer Drugs Revenue, 2018-2030
6.3.2 US Peptic Ulcer Drugs Market Size, 2018-2030
6.3.3 Canada Peptic Ulcer Drugs Market Size, 2018-2030
6.3.4 Mexico Peptic Ulcer Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Peptic Ulcer Drugs Revenue, 2018-2030
6.4.2 Germany Peptic Ulcer Drugs Market Size, 2018-2030
6.4.3 France Peptic Ulcer Drugs Market Size, 2018-2030
6.4.4 U.K. Peptic Ulcer Drugs Market Size, 2018-2030
6.4.5 Italy Peptic Ulcer Drugs Market Size, 2018-2030
6.4.6 Russia Peptic Ulcer Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Peptic Ulcer Drugs Market Size, 2018-2030
6.4.8 Benelux Peptic Ulcer Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Peptic Ulcer Drugs Revenue, 2018-2030
6.5.2 China Peptic Ulcer Drugs Market Size, 2018-2030
6.5.3 Japan Peptic Ulcer Drugs Market Size, 2018-2030
6.5.4 South Korea Peptic Ulcer Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Peptic Ulcer Drugs Market Size, 2018-2030
6.5.6 India Peptic Ulcer Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Peptic Ulcer Drugs Revenue, 2018-2030
6.6.2 Brazil Peptic Ulcer Drugs Market Size, 2018-2030
6.6.3 Argentina Peptic Ulcer Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peptic Ulcer Drugs Revenue, 2018-2030
6.7.2 Turkey Peptic Ulcer Drugs Market Size, 2018-2030
6.7.3 Israel Peptic Ulcer Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Peptic Ulcer Drugs Market Size, 2018-2030
6.7.5 UAE Peptic Ulcer Drugs Market Size, 2018-2030
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Peptic Ulcer Drugs Major Product Offerings
7.1.4 AstraZeneca Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca Key News
7.2 Livzon Pharmaceutical
7.2.1 Livzon Pharmaceutical Corporate Summary
7.2.2 Livzon Pharmaceutical Business Overview
7.2.3 Livzon Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.2.4 Livzon Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.2.5 Livzon Pharmaceutical Key News
7.3 Jiangsu Aosaikang Pharmaceutical
7.3.1 Jiangsu Aosaikang Pharmaceutical Corporate Summary
7.3.2 Jiangsu Aosaikang Pharmaceutical Business Overview
7.3.3 Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.3.4 Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.3.5 Jiangsu Aosaikang Pharmaceutical Key News
7.4 CTTQ
7.4.1 CTTQ Corporate Summary
7.4.2 CTTQ Business Overview
7.4.3 CTTQ Peptic Ulcer Drugs Major Product Offerings
7.4.4 CTTQ Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.4.5 CTTQ Key News
7.5 Luoxin Pharmaceuticals
7.5.1 Luoxin Pharmaceuticals Corporate Summary
7.5.2 Luoxin Pharmaceuticals Business Overview
7.5.3 Luoxin Pharmaceuticals Peptic Ulcer Drugs Major Product Offerings
7.5.4 Luoxin Pharmaceuticals Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.5.5 Luoxin Pharmaceuticals Key News
7.6 Takeda
7.6.1 Takeda Corporate Summary
7.6.2 Takeda Business Overview
7.6.3 Takeda Peptic Ulcer Drugs Major Product Offerings
7.6.4 Takeda Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.6.5 Takeda Key News
7.7 Eisai
7.7.1 Eisai Corporate Summary
7.7.2 Eisai Business Overview
7.7.3 Eisai Peptic Ulcer Drugs Major Product Offerings
7.7.4 Eisai Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.7.5 Eisai Key News
7.8 Jumpcan Pharmaceutical
7.8.1 Jumpcan Pharmaceutical Corporate Summary
7.8.2 Jumpcan Pharmaceutical Business Overview
7.8.3 Jumpcan Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.8.4 Jumpcan Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.8.5 Jumpcan Pharmaceutical Key News
7.9 Zhejiang Conba Pharmaceutical
7.9.1 Zhejiang Conba Pharmaceutical Corporate Summary
7.9.2 Zhejiang Conba Pharmaceutical Business Overview
7.9.3 Zhejiang Conba Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.9.4 Zhejiang Conba Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.9.5 Zhejiang Conba Pharmaceutical Key News
7.10 Youcare Pharmaceutical
7.10.1 Youcare Pharmaceutical Corporate Summary
7.10.2 Youcare Pharmaceutical Business Overview
7.10.3 Youcare Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.10.4 Youcare Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.10.5 Youcare Pharmaceutical Key News
7.11 Chongqing Lummy Pharmaceutical
7.11.1 Chongqing Lummy Pharmaceutical Corporate Summary
7.11.2 Chongqing Lummy Pharmaceutical Business Overview
7.11.3 Chongqing Lummy Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.11.4 Chongqing Lummy Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.11.5 Chongqing Lummy Pharmaceutical Key News
7.12 Huadong Medicine
7.12.1 Huadong Medicine Corporate Summary
7.12.2 Huadong Medicine Business Overview
7.12.3 Huadong Medicine Peptic Ulcer Drugs Major Product Offerings
7.12.4 Huadong Medicine Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.12.5 Huadong Medicine Key News
7.13 Hansoh Pharmaceutical
7.13.1 Hansoh Pharmaceutical Corporate Summary
7.13.2 Hansoh Pharmaceutical Business Overview
7.13.3 Hansoh Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.13.4 Hansoh Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.13.5 Hansoh Pharmaceutical Key News
7.14 CR Double-Crane
7.14.1 CR Double-Crane Corporate Summary
7.14.2 CR Double-Crane Business Overview
7.14.3 CR Double-Crane Peptic Ulcer Drugs Major Product Offerings
7.14.4 CR Double-Crane Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.14.5 CR Double-Crane Key News
7.15 Hunan Warrant Pharmaceutical
7.15.1 Hunan Warrant Pharmaceutical Corporate Summary
7.15.2 Hunan Warrant Pharmaceutical Business Overview
7.15.3 Hunan Warrant Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.15.4 Hunan Warrant Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.15.5 Hunan Warrant Pharmaceutical Key News
7.16 Changzhou Siyao Pharmaceuticals
7.16.1 Changzhou Siyao Pharmaceuticals Corporate Summary
7.16.2 Changzhou Siyao Pharmaceuticals Business Overview
7.16.3 Changzhou Siyao Pharmaceuticals Peptic Ulcer Drugs Major Product Offerings
7.16.4 Changzhou Siyao Pharmaceuticals Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.16.5 Changzhou Siyao Pharmaceuticals Key News
7.17 Chongqing Pharscin Pharmaceutical
7.17.1 Chongqing Pharscin Pharmaceutical Corporate Summary
7.17.2 Chongqing Pharscin Pharmaceutical Business Overview
7.17.3 Chongqing Pharscin Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.17.4 Chongqing Pharscin Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.17.5 Chongqing Pharscin Pharmaceutical Key News
7.18 Lionco Pharmaceutical
7.18.1 Lionco Pharmaceutical Corporate Summary
7.18.2 Lionco Pharmaceutical Business Overview
7.18.3 Lionco Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.18.4 Lionco Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.18.5 Lionco Pharmaceutical Key News
7.19 Jiangsu Wuzhong Pharmaceutical
7.19.1 Jiangsu Wuzhong Pharmaceutical Corporate Summary
7.19.2 Jiangsu Wuzhong Pharmaceutical Business Overview
7.19.3 Jiangsu Wuzhong Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.19.4 Jiangsu Wuzhong Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.19.5 Jiangsu Wuzhong Pharmaceutical Key News
7.20 Cisen Pharmaceutical
7.20.1 Cisen Pharmaceutical Corporate Summary
7.20.2 Cisen Pharmaceutical Business Overview
7.20.3 Cisen Pharmaceutical Peptic Ulcer Drugs Major Product Offerings
7.20.4 Cisen Pharmaceutical Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.20.5 Cisen Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Peptic Ulcer Drugs Market Opportunities & Trends in Global Market
Table 2. Peptic Ulcer Drugs Market Drivers in Global Market
Table 3. Peptic Ulcer Drugs Market Restraints in Global Market
Table 4. Key Players of Peptic Ulcer Drugs in Global Market
Table 5. Top Peptic Ulcer Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Peptic Ulcer Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Peptic Ulcer Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Peptic Ulcer Drugs Product Type
Table 9. List of Global Tier 1 Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Peptic Ulcer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Peptic Ulcer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Peptic Ulcer Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Peptic Ulcer Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Peptic Ulcer Drugs Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Peptic Ulcer Drugs Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Peptic Ulcer Drugs Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Peptic Ulcer Drugs Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Peptic Ulcer Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Peptic Ulcer Drugs Revenue, (US$, Mn), 2023-2030
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Peptic Ulcer Drugs Product Offerings
Table 32. AstraZeneca Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 33. Livzon Pharmaceutical Corporate Summary
Table 34. Livzon Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 35. Livzon Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 36. Jiangsu Aosaikang Pharmaceutical Corporate Summary
Table 37. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 38. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 39. CTTQ Corporate Summary
Table 40. CTTQ Peptic Ulcer Drugs Product Offerings
Table 41. CTTQ Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 42. Luoxin Pharmaceuticals Corporate Summary
Table 43. Luoxin Pharmaceuticals Peptic Ulcer Drugs Product Offerings
Table 44. Luoxin Pharmaceuticals Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 45. Takeda Corporate Summary
Table 46. Takeda Peptic Ulcer Drugs Product Offerings
Table 47. Takeda Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 48. Eisai Corporate Summary
Table 49. Eisai Peptic Ulcer Drugs Product Offerings
Table 50. Eisai Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 51. Jumpcan Pharmaceutical Corporate Summary
Table 52. Jumpcan Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 53. Jumpcan Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 54. Zhejiang Conba Pharmaceutical Corporate Summary
Table 55. Zhejiang Conba Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 56. Zhejiang Conba Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 57. Youcare Pharmaceutical Corporate Summary
Table 58. Youcare Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 59. Youcare Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 60. Chongqing Lummy Pharmaceutical Corporate Summary
Table 61. Chongqing Lummy Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 62. Chongqing Lummy Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 63. Huadong Medicine Corporate Summary
Table 64. Huadong Medicine Peptic Ulcer Drugs Product Offerings
Table 65. Huadong Medicine Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 66. Hansoh Pharmaceutical Corporate Summary
Table 67. Hansoh Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 68. Hansoh Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 69. CR Double-Crane Corporate Summary
Table 70. CR Double-Crane Peptic Ulcer Drugs Product Offerings
Table 71. CR Double-Crane Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 72. Hunan Warrant Pharmaceutical Corporate Summary
Table 73. Hunan Warrant Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 74. Hunan Warrant Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 75. Changzhou Siyao Pharmaceuticals Corporate Summary
Table 76. Changzhou Siyao Pharmaceuticals Peptic Ulcer Drugs Product Offerings
Table 77. Changzhou Siyao Pharmaceuticals Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 78. Chongqing Pharscin Pharmaceutical Corporate Summary
Table 79. Chongqing Pharscin Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 80. Chongqing Pharscin Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 81. Lionco Pharmaceutical Corporate Summary
Table 82. Lionco Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 83. Lionco Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 84. Jiangsu Wuzhong Pharmaceutical Corporate Summary
Table 85. Jiangsu Wuzhong Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 86. Jiangsu Wuzhong Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
Table 87. Cisen Pharmaceutical Corporate Summary
Table 88. Cisen Pharmaceutical Peptic Ulcer Drugs Product Offerings
Table 89. Cisen Pharmaceutical Peptic Ulcer Drugs Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Peptic Ulcer Drugs Segment by Type in 2022
Figure 2. Peptic Ulcer Drugs Segment by Application in 2022
Figure 3. Global Peptic Ulcer Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Peptic Ulcer Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Peptic Ulcer Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peptic Ulcer Drugs Revenue in 2022
Figure 8. By Type - Global Peptic Ulcer Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Peptic Ulcer Drugs Revenue Market Share, 2018-2030
Figure 10. By Region - Global Peptic Ulcer Drugs Revenue Market Share, 2018-2030
Figure 11. By Country - North America Peptic Ulcer Drugs Revenue Market Share, 2018-2030
Figure 12. US Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Peptic Ulcer Drugs Revenue Market Share, 2018-2030
Figure 16. Germany Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. France Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Peptic Ulcer Drugs Revenue Market Share, 2018-2030
Figure 24. China Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. India Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Peptic Ulcer Drugs Revenue Market Share, 2018-2030
Figure 30. Brazil Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Peptic Ulcer Drugs Revenue Market Share, 2018-2030
Figure 33. Turkey Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. AstraZeneca Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Livzon Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Jiangsu Aosaikang Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. CTTQ Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Luoxin Pharmaceuticals Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Takeda Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eisai Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Jumpcan Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Zhejiang Conba Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Youcare Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Chongqing Lummy Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Huadong Medicine Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hansoh Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CR Double-Crane Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hunan Warrant Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Changzhou Siyao Pharmaceuticals Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Chongqing Pharscin Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Lionco Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Jiangsu Wuzhong Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Cisen Pharmaceutical Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
